Delirium is a condition of acute disturbance in attention and awareness along with disturbances in cognition. It is a symptom of deranged homeostasis and an early sign of infection or hypoxia. The occurrence of COVID-19 brought a catastrophic reduction in delirium monitoring, prevention, and patient care due to several organizational issues like lack of personnel, increased use of benzodiazepines and restricted family visitation.
For the future development of an ideal intensive care unit (ICU) it is important to make the patients free from delirium. As delirium is associated with worse ICU-related outcomes and long-term cognitive impairment in critical illnesses.
Screening for delirium requires limited time and effort. Completing good sedation practices by novel ICU design and connectivity will facilitate non-pharmacological sedation, anxiolysis and comfort which can further be supplemented by balanced pharmacological interventions when necessary. Improvements in the ICU sound, light control, floor planning, and room arrangement can also facilitate a healing environment which would eventually minimize stressors and aid delirium prevention and management.
The fundamental prerequisite to realize the delirium-free ICU, is an awake non-sedated, pain-free comfortable patient whose management follows the A to F (A–F) bundle. Moreover, gaining (G) insight into patient needs, delivering holistic care with a ‘home-like’ (H) environment, and redefining ICU architectural design (I).
The most important thing is to obtain a delirium-free world. It requires optimization of design of ICU, environmental factors, management, time spent with the patient and family by the criticare teams during their routine ICU care.
Read more such content on Hidoc Dr | Medical Learning App for Doctors
1.
Higher levels of HIF2α found to slow down aggressive childhood cancer
2.
Oral drug combination extends progression-free survival in advanced ER-positive breast cancer
3.
Guidelines for cervical cancer screening and the risk of preterm birth in young women.
4.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
5.
Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer
1.
Revolutionizing Cancer Care: The Impact of Darzalex Faspro
2.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
3.
Progressive Models in Hematology for Healthcare Excellence
4.
Quality of Life Following Organ Function Preserving Oncologic Innovation
5.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation